Literature DB >> 30838705

Dachengqi decoction alleviates acute lung injury and inhibits inflammatory cytokines production through TLR4/NF-κB signaling pathway in vivo and in vitro.

XingXing Hu1, Shang Liu2, Jin Zhu3, HaiBin Ni1.   

Abstract

BACKGROUND AND OBJECTIVES: Sepsis that arises from uncontrolled pulmonary inflammation could induce acute lung injury (ALI), leading to the high death rate. Dachengqi decoction (DCQD) is a common traditional Chinese herbal medicine with strong anti-inflammatory effects. The current study aimed to explore the effect of DCQD on the inflammatory cytokines production, the aquaporin-1 (AQP-1) and AQP-5 protein expression in lipopolysaccharide (LPS)-induced ALI models, and the potential mechanisms underlying its effects.
METHODS: Sprague-Dawley rats and HULEC-5a cells were used as study models in the research. To detect related molecules in the study, the real-time polymerase chain reaction analysis, cell counting kit-8 assay, Western blot analysis, and enzyme-linked immunosorbent assay were performed.
RESULTS: DCQD could inhibit the expression of LPS-induced inflammatory cytokines, including interleukin-6 (IL-6), IL-8, and tumor necrosis factor-α (TNF-α), in lung tissues and could reduce pulmonary edema by upregulating the expression of AQP-1 and AQP-5 in rats with LPS-induced ALI. Moreover, the results suggested that the toll-like receptor 4 (TLR4)/NF-κB signaling is indispensable for DCQD to increase the expression of AQP-1 and AQP-5 and inhibits the production of IL-6, IL-8, and TNF-α in LPS-induced HULEC-5a cells.
CONCLUSION: The results of our study suggested that DCQD suppresses the TLR4/NF-κB signaling pathway, increases the protein expression of AQP-1 and AQP-5, and inhibits the production of inflammatory cytokines, by which it may alleviate the inflammatory reactions in ALI and benefit the treatments.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Dachengqi decoction (DCQD); acute lung injury (ALI); aquaporin-1 (AQP-1); aquaporin-5 (AQP-5); inflammatory cytokines

Mesh:

Substances:

Year:  2019        PMID: 30838705     DOI: 10.1002/jcb.27615

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

Review 2.  Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications.

Authors:  Ekta Yadav; Niket Yadav; Ariel Hus; Jagjit S Yadav
Journal:  Respir Med       Date:  2020-10-17       Impact factor: 3.415

3.  PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway.

Authors:  Shilong Zhao; Jing Gao; Jing Li; Shilei Wang; Congcong Yuan; Qiuhong Liu
Journal:  Inflammation       Date:  2021-05-20       Impact factor: 4.092

4.  MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.

Authors:  Shan Fu
Journal:  Int J Mol Med       Date:  2020-05-12       Impact factor: 4.101

5.  A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection.

Authors:  Peng Wang; Ronghua Luo; Min Zhang; Yaqing Wang; Tianzhang Song; Tingting Tao; Zhongyu Li; Lin Jin; Hongyi Zheng; Wenwen Chen; Mengqian Zhao; Yongtang Zheng; Jianhua Qin
Journal:  Cell Death Dis       Date:  2020-12-08       Impact factor: 8.469

6.  Oxyberberine Prevented Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Mitophagy.

Authors:  Runmin Zhao; Bingxia Wang; Dasheng Wang; Benhe Wu; Peiyu Ji; Dingyu Tan
Journal:  Oxid Med Cell Longev       Date:  2021-02-26       Impact factor: 6.543

7.  MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway.

Authors:  Hu Gao; Dongqiong Xiao; Linbo Gao; Xihong Li
Journal:  Int J Mol Med       Date:  2020-05-19       Impact factor: 4.101

8.  Protective effect of S-nitrosoglutathione pretreatment on acute lung injury in septic rats.

Authors:  Zhou-Feng Wang; Yu-Min Yang; Heng Fan
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

9.  A randomized controlled trial of Chinese traditional medicine Dachengqi Decoction in the treatment of postoperative intestinal function recovery.

Authors:  Yuwen Luo; Xingyu Feng; Deqing Wu; Junjiang Wang; Zejian Lyv; Jiabin Zheng; Kheng Tian Lim; Yong Li
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

10.  Nuezhenide Exerts Anti-Inflammatory Activity through the NF-κB Pathway.

Authors:  Qin-Qin Wang; Shan Han; Xin-Xing Li; Renyikun Yuan; Youqiong Zhuo; Xinxin Chen; Chenwei Zhang; Yangling Chen; Hongwei Gao; Li-Chun Zhao; Shilin Yang
Journal:  Curr Mol Pharmacol       Date:  2021       Impact factor: 3.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.